Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roman Prymula

Showing results (51-60 of 78) with videos related to

Pageof 8
Sort By:
BMC Infectious Diseases|June 16, 2010
Central European Vaccination Advisory Group (CEVAG) guidance statement on recommendations for influenza vaccination in childrenVytautas Usonis, Ioana Anca, Francis André, et al.
The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine|April 24, 2010
Safety and immunogenicity of the HPV-16/18 AS04-adjuvanted vaccine: a randomized, controlled trial in adolescent girlsDoris M Rivera Medina, Alejandra Valencia, Alet de Velasquez, et al.
Journal of Medical Internet Research|May 16, 2020
Complex Reporting of the COVID-19 Epidemic in the Czech Republic: Use of an Interactive Web-Based App in PracticeMartin Komenda, Vojtěch Bulhart, Matěj Karolyi, et al.
Lancet (London, England)|February 4, 2014
Protection against varicella with two doses of combined measles-mumps-rubella-varicella vaccine versus one dose of monovalent varicella vaccine: a multicentre, observer-blind, randomised, controlled trialRoman Prymula, Marianne Riise Bergsaker, Susanna Esposito, et al.
Vaccine|April 13, 2010
Central European Vaccination Advisory Group (CEVAG) guidance statement on recommendations for 2009 pandemic influenza A(H1N1) vaccinationRoman Chlibek, Ioana Anca, Francis André, et al.
Central European Journal of Public Health|September 13, 2012
Opportunity for healthy ageing: lessening the burden of adult pneumococcal disease in Central and Eastern Europe, and IsraelEndre Ludwig, Serhat Unal, Miron Bogdan, et al.
The Lancet. Infectious Diseases|February 16, 2019
Protection against varicella with two doses of combined measles-mumps-rubella-varicella vaccine or one dose of monovalent varicella vaccine: 10-year follow-up of a phase 3 multicentre, observer-blind, randomised, controlled trialMichael Povey, Ouzama Henry, Marianne A Riise Bergsaker, et al.
Vaccine|December 5, 2016
Persistence of bactericidal antibodies following booster vaccination with 4CMenB at 12, 18 or 24months and immunogenicity of a fifth dose administered at 4years of age-a phase 3 extension to a randomised controlled trialMildred A Iro, Matthew D Snape, Merryn Voysey, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|October 18, 2017
Persistence of immunity after vaccination with a capsular group B meningococcal vaccine in 3 different toddler schedulesManish Sadarangani, Tim Sell, Mildred A Iro, et al.
Vaccine|May 10, 2017
Corrigendum to "Persistence of bactericidal antibodies following booster vaccination with 4CMenB at 12, 18 or 24months and immunogenicity of a fifth dose administered at 4years of age-a phase 3 extension to a randomised controlled trial" [Vaccine 35 (2017) 395-402]Mildred A Iro, Matthew D Snape, Merryn Voysey, et al.
Pageof 8

Showing results (51-60 of 78) with videos related to

Sort By:
Pageof 8
BMC Infectious Diseases|June 16, 2010
Central European Vaccination Advisory Group (CEVAG) guidance statement on recommendations for influenza vaccination in childrenVytautas Usonis, Ioana Anca, Francis André, et al.
The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine|April 24, 2010
Safety and immunogenicity of the HPV-16/18 AS04-adjuvanted vaccine: a randomized, controlled trial in adolescent girlsDoris M Rivera Medina, Alejandra Valencia, Alet de Velasquez, et al.
Journal of Medical Internet Research|May 16, 2020
Complex Reporting of the COVID-19 Epidemic in the Czech Republic: Use of an Interactive Web-Based App in PracticeMartin Komenda, Vojtěch Bulhart, Matěj Karolyi, et al.
Lancet (London, England)|February 4, 2014
Protection against varicella with two doses of combined measles-mumps-rubella-varicella vaccine versus one dose of monovalent varicella vaccine: a multicentre, observer-blind, randomised, controlled trialRoman Prymula, Marianne Riise Bergsaker, Susanna Esposito, et al.
Vaccine|April 13, 2010
Central European Vaccination Advisory Group (CEVAG) guidance statement on recommendations for 2009 pandemic influenza A(H1N1) vaccinationRoman Chlibek, Ioana Anca, Francis André, et al.
Central European Journal of Public Health|September 13, 2012
Opportunity for healthy ageing: lessening the burden of adult pneumococcal disease in Central and Eastern Europe, and IsraelEndre Ludwig, Serhat Unal, Miron Bogdan, et al.
The Lancet. Infectious Diseases|February 16, 2019
Protection against varicella with two doses of combined measles-mumps-rubella-varicella vaccine or one dose of monovalent varicella vaccine: 10-year follow-up of a phase 3 multicentre, observer-blind, randomised, controlled trialMichael Povey, Ouzama Henry, Marianne A Riise Bergsaker, et al.
Vaccine|December 5, 2016
Persistence of bactericidal antibodies following booster vaccination with 4CMenB at 12, 18 or 24months and immunogenicity of a fifth dose administered at 4years of age-a phase 3 extension to a randomised controlled trialMildred A Iro, Matthew D Snape, Merryn Voysey, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|October 18, 2017
Persistence of immunity after vaccination with a capsular group B meningococcal vaccine in 3 different toddler schedulesManish Sadarangani, Tim Sell, Mildred A Iro, et al.
Vaccine|May 10, 2017
Corrigendum to "Persistence of bactericidal antibodies following booster vaccination with 4CMenB at 12, 18 or 24months and immunogenicity of a fifth dose administered at 4years of age-a phase 3 extension to a randomised controlled trial" [Vaccine 35 (2017) 395-402]Mildred A Iro, Matthew D Snape, Merryn Voysey, et al.
Pageof 8